Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-18-001086
Filing Date
2018-04-02
Accepted
2018-04-02 16:36:56
Documents
49
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K zk1821437.htm 10-K 943840
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 10011
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 9764
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 6488
11 image00001.jpg GRAPHIC 4324
  Complete submission text file 0001178913-18-001086.txt   2977285

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT atms-20171231.xml EX-101.INS 413413
6 XBRL TAXONOMY EXTENSION SCHEMA atms-20171231.xsd EX-101.SCH 32583
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atms-20171231_cal.xml EX-101.CAL 30874
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atms-20171231_def.xml EX-101.DEF 105842
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atms-20171231_lab.xml EX-101.LAB 222849
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atms-20171231_pre.xml EX-101.PRE 175997
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24431 | Film No.: 18729415
SIC: 2890 Miscellaneous Chemical Products